United Therapeutics Corp. (UTHR)

552.27 +7.58 (+1.39%) USD  |  NASDAQ  |  Jun 09, 15:51
More

United Therapeutics SG&A Expense (Quarterly) : 156.60M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for UTHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
MannKind Corp. 108.17M
Catalyst Pharmaceuticals, Inc. 43.52M
Insmed, Inc. 247.26M
Alnylam Pharmaceuticals, Inc. 322.55M
BioMarin Pharmaceutical, Inc. 258.30M